Bioisosteric Replacement in the Search for Biologically Active Compounds: Design, Synthesis and Anti-Inflammatory Activity of Novel [1,2,4]triazino[2,3-c]quinazolines
<b>Background:</b> Designing novel biologically active compounds with anti-inflammatory properties based on condensed quinazolines is a significant area of interest in modern medicinal chemistry. In the present study, we describe the development of promising new bioactive molecules through the bioisosteric replacement of a carbon atom with a sulfur atom in anti-inflammatory agents, specifically 3-methyl-2-oxo-2<i>H</i>-[1,2,4]triazino[2,3-<i>c</i>]quinazolin-6-yl)butanoate. <b>Methods:</b> Design and synthetic studies have led to the series of previously unknown substituted 2-[((3-R-2-oxo-2<i>H</i>-[1,2,4]triazino[2,3-<i>c</i>]quinazolin-6-yl)methyl)thio]carboxylic acids and their esters. These compounds were synthesized by reacting 6-chloroalkyl-3-R-2<i>H</i>-[1,2,4]triazino[2,3-<i>c</i>]quinazolin-2-ones with sulfanylalkyl carboxylic acids and their functional derivatives. The purity and structure of the obtained compounds were confirmed using a set of physicochemical methods, including elemental analysis, HPLC-MS, and <sup>1</sup>H NMR spectroscopy. Molecular modeling, predicted toxicity, drug-likeness, and pharmacokinetics data were used to select compounds for evaluation of their effects on acute aseptic inflammation (carrageenan-induced paw edema test) and on markers of the inflammatory process. <b>Results:</b> The compound 2-((1-(3-methyl-2-oxo-2<i>H</i>-[1,2,4]triazino[2,3-<i>c</i>]quinazolin-6-yl)ethyl)thio)acetic acid (compound <b>2e</b>) was identified as the most active anti-inflammatory agent (AA = 53.41%), demonstrating significant inhibition of both paw edema development and the generation of pro-inflammatory cytokines and mediators. <b>Conclusions:</b> Results from docking studies and analysis of "structure-affinity" correlations revealed that these compounds are promising candidates for further modification and detailed investigation of their anti-inflammatory activity.
Authors
- Valentyn Oksenych (ORCID: https://orcid.org/0000-0002-5088-3791)
- С. І. Коваленко (ORCID: https://orcid.org/0000-0001-8017-9108)
- Oleksandr Grytsak
- Олексій Воскобойнік (ORCID: https://orcid.org/0000-0002-5790-3564)
- Hanna Severina (ORCID: https://orcid.org/0000-0003-2894-9384)
- Oleksandr Kamyshnyi (ORCID: https://orcid.org/0000-0003-3141-4436)
- Igor F. Belenichev (ORCID: https://orcid.org/0000-0003-1273-5314)
- Kostiantyn Shabelnyk (ORCID: https://orcid.org/0000-0003-2008-8380)
- Victor Ryzhenko (ORCID: https://orcid.org/0000-0003-3466-7148)
Institutions
- National University Zaporizhzhia Polytechnic (UA)
- Norwegian University of Science and Technology (NO)
- Zaporizhzhia State Medical and Pharmaceutical University (UA)
- Karolinska Institutet (SE)
- National University of Pharmacy (UA)
- I.Horbachevsky Ternopil National Medical University (UA)
- University of Bergen (NO)
- Oles Honchar Dnipro National University (UA)
Publication Details
- Journal
- Pharmaceuticals
- Published
- 2024-10-28
- DOI
- https://doi.org/10.3390/ph17111437
- Citations
- 2
- Primary Topic
- Quinazolinone synthesis and applications
- Type
- article
- Field-Weighted Citation Impact
- 0.50
Funders
- Karolinska Institutet
- Norges Forskningsråd